Skip to content

US Dept of Defense – Breast Cancer Research Program

Home / Funding Opportunity / US Dept of Defense – Breast Cancer Research Program

US Dept of Defense – Breast Cancer Research Program

twitterlinkedin

Breakthrough Award Levels 1 and 2 HT942524BCRPBTA12

  • Funding Level 1 – up to USD$450,000 over 3 years or
  • Funding Level 1 – up to USD$750,000 over 3 years for Partnering PI option or
  • Funding Level 2 – up to USD$1M over 3 years or
  • Funding Level 2 – up to USD $1.5M over 3 years for Partnering PI option or
  • Funding Level 2 – populations science and prevention studies – up to USD$1.5M over 4 years or
  • Funding Level 2 – populations science and prevention studies – up to USD$2M over 4 yeas with Partnering PI option
  • Letters of Intent due 16 May 2024
  • supports promising research that has high potential to lead to or make breakthroughs in breast cancer
  • Document: Funding Opportunity – HT942524BCRPBTA12-GG

 

Breakthrough Award Level 3HT942524BCRPBTA3

  • up to USD$4M over 4 years or
  • up to USD$5M over 4 years with Partnering PI option
  • Pre-proposals due 14 May 2024
  • Supports promising research that has high potential to lead to or make breakthroughs in breast cancer
  • Document: Funding Opportunity – HT942524BCRPBTA3-GG

 

Breakthrough Award Level 4HT942524BCRPBTA4

  • up to USD$15M over 4 years
  • pre-proposals due 14 May 2024
  • Supports promising research that has high potential to lead to or make breakthroughs in breast cancer
  • Document: Funding Opportunity – HT942524BCRPBTA4-GG

 

Clinical Research Extension Award – HT942524BCRPCREA 

  • up to USD$5M over 4 years or
  • up to USD$6M over 4 years with Partnering PI option
  • letters of intent due 23 May 2024
  • supports research that extends or expands the data collection, follow-up and analysis of breast cancer clinical studies
  • Document: HT942524BCRPCREA-GG

 

Era of Hope Scholar Award – HT942524BCRPEOHS

  • up to USD$3.5M over 4 years
  • letters of intent due 23 May 2024
  • supports individual ECRs (<6 years) who have demonstrated significant potential to to effect meaningful change in breast cancer
  • applicants should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention
  • research team must include at least 2 breast cancer advocates
  • Document: Funding Opportunity – HT942524BCRPEOHS-GG

 

Apply here

Document

Breast Cancer Research Program Summary Table: FY24 BCRP PA Reference Table FINAL

You may be also interested in ...